Embolx Revenue and Competitors
Estimated Revenue & Valuation
- Embolx's estimated annual revenue is currently $4.5M per year.
- Embolx's estimated revenue per employee is $251,000
Employee Data
- Embolx has 18 Employees.
- Embolx grew their employee count by -14% last year.
Embolx's People
Name | Title | Email/Phone |
---|---|---|
1 | President & CEO | Reveal Email/Phone |
2 | Marketing Manager | Reveal Email/Phone |
3 | Medical Consultant | Reveal Email/Phone |
4 | RA/QA Consultant | Reveal Email/Phone |
5 | RA/QA Specialist | Reveal Email/Phone |
Embolx Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $24.1M | 96 | 19% | N/A | N/A |
#2 | $9.5M | 38 | 12% | N/A | N/A |
#3 | $4M | 16 | -11% | N/A | N/A |
#4 | $7.8M | 31 | -3% | N/A | N/A |
#5 | $5M | 20 | -5% | N/A | N/A |
#6 | $49.9M | 199 | -8% | N/A | N/A |
#7 | $16.8M | 67 | -17% | $63.2M | N/A |
#8 | $9.3M | 37 | -7% | N/A | N/A |
#9 | $36.6M | 146 | 22% | N/A | N/A |
#10 | $64.3M | 205 | 3% | $502M | N/A |
What Is Embolx?
Embolx is an emerging commercial-stage medical device company in Silicon Valley developing microcatheters for arterial embolization procedures. Embolx is committed to dramatically improving the treatment of a variety of conditions including cancerous tumors, benign prostatic hyperplasia and uterine fibroids. The Sniper balloon occlusion microcatheter sets a new standard for precise embolic delivery and superior target filling by controlling pressure to direct blood flow while protecting non-target surrounding tissues.
keywords:N/AN/A
Total Funding
18
Number of Employees
$4.5M
Revenue (est)
-14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.5M | 18 | N/A | N/A |
#2 | $3M | 18 | 0% | N/A |
#3 | $2.9M | 18 | 20% | N/A |
#4 | N/A | 18 | 157% | $9M |
#5 | $1.6M | 18 | 100% | N/A |